Definitive Contract 75N93023C00040
Award Date
9/30/23
Potential Completion Date
9/29/28
Potential Value
$3.3M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541512 - Computer Systems Design Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02111, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
24
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive, cost-no-fee federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The $13,600,565.07 contract is for an "ADJUVANT DEVELOPMENT PROGRAM" and has an ultimate completion date of September 29, 2025. Boston Children's Hospital, a non-profit pediatric teaching hospital and research center,...
This is a $10,978,171.99 definitive cost-reimbursement contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to The Children's Hospital Corporation (doing business as Boston Children's Hospital). The contract is for the Vaccine Adjuvant Discovery Program, with the objective of identifying novel adjuvant candidates that can be used to enhance the efficacy of...
This is a $8,330,482.00 definitive cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit organization. The contract is for the Vaccine Adjuvant Discovery Program (VADP), which supports the identification and characterization of novel, effective, and safe vaccine adjuvants. The work involves research across areas such as high-throughput screening,...
This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The $3,300,000.00 definitive contract was awarded on September 30, 2001 with a completion date of September 29, 2004. The contract is not set-aside. Through this award, Boston Children's Hospital has provided a range of services...
This is a $9,730,025.00 definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, which does not have a set-aside designation, is for a scientific study with an ultimate completion date of February 22, 2028. Boston Children's Hospital, an institution affiliated with Harvard Medical School, has...
This is a $31,468,032.25 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, titled "FLUMED FOR OTHER FUNCTIONS," has a firm fixed-price pricing arrangement and an ultimate completion date of January 30, 2023. The contract does not have a set-aside designation. Through this award, Boston...
This is a $5,092,787.07 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The contract is for COVID-19 research focused on critically ill children and does not have a set-aside designation. Boston Children's Hospital is a non-profit pediatric teaching hospital and research center affiliated with Harvard Medical School. Through this contract, the hospital is...
This is a $24,899,418.92 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract is for a COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Vaccine Effectiveness (VE) study, with a period of performance ending on September 15, 2026. The contract does not have a set-aside...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital Corporation, doing business as Boston Children's Hospital, for influenza vaccine effectiveness for children in the United States. The contract has a firm fixed price of $1,939,144.49 and does not have a set-aside designation. Boston Children's Hospital is a pediatric teaching hospital and research center affiliated with Harvard Medical...
This is a $24,785,826.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to develop innovative and safe multivalent anti-opioid vaccines that protect against heroin and fentanyl. The contract, which has a period of performance through September 29, 2027, is not set aside. The contract originated from a...